Search

Your search keyword '"Hahn, Christopher N"' showing total 397 results

Search Constraints

Start Over You searched for: Author "Hahn, Christopher N" Remove constraint Author: "Hahn, Christopher N"
397 results on '"Hahn, Christopher N"'

Search Results

3. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

4. TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

5. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41

7. Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma

9. Novel modes of MPL activation in triple-negative myeloproliferative neoplasms

10. Genomic subtyping and therapeutic targeting of acute erythroleukemia

11. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

12. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

13. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

14. IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation

15. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution

16. ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

17. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

24. Seronegative Rheumatoid Arthritis and Innate Immune Activation is Frequent in Myeloid Neoplasms with Isocitrate Dehydrogenase 1/2 Mutations

25. TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

27. TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome

28. Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome

29. Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2 and DDX41

30. Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies

31. Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin–restricted miRNA antagonists of miR-27

32. Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations

34. GATA2 is required for lymphatic vessel valve development and maintenance

35. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature

37. Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema

38. Childhood acute myeloid leukemia shows a high level of germline predisposition

41. Cover, Volume 42, Issue 11

43. GATA2 deficiency syndrome: A decade of discovery

44. The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy

45. Childhood acute myeloid leukemia shows a high level of germline predisposition

47. ARMC5 Mutations Are Common in Familial Bilateral Macronodular Adrenal Hyperplasia

Catalog

Books, media, physical & digital resources